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Conclusions Available data on Se intake and status in Brit-
ish vegetarians, as well as the relationship between their 
secular changes in the UK and changes in CRC risk in this 
dietary group, are compatible with the hypothesis that low 
Se status may contribute to the largely null results of stud-
ies of CRC risk in vegetarians in the UK.
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Introduction
According to the World Cancer Research Fund (WCRF), 
there is convincing evidence that processed (i.e. preserved 
by smoking, curing or salting, or addition of chemical pre-
servatives) and red meats, as well as foods high in fibre, 
are causative risk factors for colorectal cancer (CRC), with 
the former increasing and the latter decreasing its risk [1]. 
The recent evaluation of the carcinogenicity of these foods 
by the International Agency for Research on Cancer has 
corroborated the findings of the WCRF by classifying 
processed meats as Group 1 carcinogen (“carcinogenic to 
humans”) and red meat as Group 2A carcinogen (“probably 
carcinogenic to humans”), based chiefly on the evidence for 
CRC [2]. It is estimated that minimizing the intake of pro-
cessed and red meats (to nil intake) could prevent 21% of 
cases of CRC in the UK, while eating a high-fibre (≥23 g 
fibre per day) diet could prevent 12% of cases [3].
In light of these findings, it seems reasonable to propose 
a vegetarian diet emphasizing minimally processed plant-
based foods as a model for risk reduction of CRC. Indeed, 
a 46% reduction of 6 year incident colon cancer risk (rectal 
cancer and CRC were not reported), but not CRC mortal-
ity [4], has been observed in American vegetarians within 
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the Adventist Health Study 1, compared to otherwise 
similar members of the Adventist Church [5]. Also, the 
authors found a positive association of total, red and white 
meat intakes with colon cancer risk; a negative association 
between legume intake and this risk; and evidence of inter-
action between high red meat intake, low legume intake, 
and high body mass in increasing the risk [5].
In the largest cohort study which purposely recruited 
a high proportion of vegetarians—the ongoing Advent-
ist Health Study 2—after a mean follow-up of 7.3 years, 
the relative hazard of incident CRC was 22% lower in all 
diet groups with reduced or nil meat intake (semivegetar-
ians, pesco-vegetarians, vegetarians and vegans) combined 
than in non-vegetarians, and the observed risk reduction in 
colon, but not rectal cancer in all types of vegetarians com-
bined was close to statistical significance (HR 0.81; 95% 
CI: 0.65–1.00, p = 0.053) [6]. In analyses of separate veg-
etarian diet groups, only pesco-vegetarians had a signifi-
cantly reduced risk of CRC incidence (HR 0.57; 95% CI: 
0.40–0.82).
The results of studies in British vegetarians—histori-
cally the only cohorts other than the Adventist cohorts with 
sufficient sample sizes to detect differences in CRC rates 
between vegetarians and non-vegetarians—have largely 
been null, both in regard to CRC mortality [7, 8] and CRC 
incidence [9–11].
CRC risk in British vegetarians—an overview 
of the published findings
Six reports on CRC risk in British vegetarians were pub-
lished thus far from three studies: Health Food Shoppers 
Study (HFSS) [7], the Oxford Vegetarian Study (OVS) [8], 
the Oxford arm of the European Prospective Investigation 
into Cancer (EPIC-Oxford) study [9, 12] and combined 
analyses from the EPIC-Oxford and the OVS [10, 11]. The 
details on study design and recruitment of subjects have 
been described elsewhere [13–15].
Briefly, the HFSS and the OVS recruitment took place 
in the 1970s and early 1980s, respectively, with follow-up 
until the late 1990s. Both cohorts comprised approximately 
11,000 subjects each, with health-conscious non-vegetari-
ans and a large proportion of vegetarians (ca. 40%). In the 
ongoing EPIC-Oxford study, a cohort of 65,429 subjects 
was recruited between 1993 and 1999, comprising ca. 30% 
of vegetarians, 15% of fish-eaters (pesco-vegetarians) and 
4% of vegans. The remaining meat-eaters included ca. 
80% of health-conscious individuals, with the rest being 
recruited from the general population. In all three studies, 
follow-up was by record linkage with the National Health 
Service Central Register.
In both the HFSS and the OVS, the CRC mortality risk 
was insignificantly lower in vegetarians than in non-vege-
tarians at 0.85 (95% CI: 0.52–1.39) [7] and 0.85 (95% CI: 
0.55–1.32) [8], respectively, after a mean follow-up of 21 
and 17 years, respectively.
In the EPIC-Oxford study, the relative rate of CRC inci-
dence was in fact higher in vegetarians than in meat-eaters 
after a mean follow-up of 10.7 years (RR 1.39; 95% CI: 
1.01–1.91), despite the total cancer incidence being bor-
derline significantly lower (P = 0.052) by 11% in vegetar-
ians [9]. Also, the standardized incidence ratio (SIR) of 101 
(95% CI: 79–128) suggested that vegetarians had incidence 
rate of CRC similar to average British citizens, while non-
vegetarians (meat-eaters and fish-eaters combined) had 
significantly lower CRC SIR (84; 95% CI: 73, 95). In line 
with these findings, the standardized mortality ratio (SMR) 
for CRC in EPIC-Oxford after the same mean follow-up 
was significantly lower in non-vegetarians than in the gen-
eral UK population (SMR 67; 95% CI: 54–82), but not in 
vegetarians (81; 95% CI: 55–115) [12]. This was despite 
the SIRs and SMRs for all malignant neoplasms being sig-
nificantly and substantially lower in both non-vegetarians 
and vegetarians than in the general population—all at 
approximately 70 [9, 12].
Subsequent reports of combined analyses of incident 
CRC risk from EPIC-Oxford and OVS were null after 
12.2 years average follow-up (RR 1.12; 95% CI: 0.87–
1.44) [10] and 14.9 years (RR 1.03; 95% CI: 0.84–1.28) 
[11]. Again, this was despite the total cancer incidence in 
vegetarians being significantly lower than in meat-eaters by 
12% in both publications. In the latter analysis, a decreased 
risk of CRC was observed in fish-eaters compared to meat-
eaters (RR 0.66; 95% CI: 0.48–0.92) [11].
It should be emphasized that chance may be one plau-
sible, at least partial explanation for the rather surprising 
findings of increased CRC risk in vegetarians, given the 
null results in all other publications from this population 
and the lower end of the 95% confidence interval being 
close to 1. It is important not to make a case against the 
established, negative health effects of processed and red 
meats or dietary patterns including these foods by selec-
tively citing the results of increased CRC risk in British 
vegetarians, as it has been done in the literature in relation 
to CRC [16], as well as coronary heart disease and type 2 
diabetes [17].
Possible causes of differences in CRC risk 
between American and British vegetarians
Fraser has proposed that the characteristics of the dietary 
pattern of the EPIC-Oxford cohort may be important to the 
inconsistency between the result of American and British 
Eur J Nutr 
1 3
studies of CRC risk in vegetarians [18]. Other than null or 
episodic intake of meat in vegetarians and increased intake 
of fruit and vegetables, their dietary pattern is similar to 
that of the UK population; however, none of its character-
istics [19] seem to be particularly relevant to CRC risk, at 
least in light of the current knowledge [1].
Also, it should be noted that the intake of meat in non-
vegetarians in the EPIC-Oxford study is relatively low at 
a median of 65 g/day in men and 54 g/day in women [9]. 
For reference, the mean national intakes in British adults 
are estimated to be 130 g in men and 89 g in women [20]. 
It appears that the differences in nutrient intakes between 
vegetarians and non-vegetarians are less pronounced in the 
EPIC-Oxford cohort, compared to those observed in the 
Adventist Health Study-2 [6, 21, 22]. However, it may be 
at least in part due to the differences in the food frequency 
questionnaires (FFQ) used in the studies, with the AHS2 
FFQ (unlike the EPIC-Oxford FFQ), allowing participants 
to choose different multiples of the standard portion size. 
Due to the lower energy density of staple plant foods, such 
as whole grains and legumes, vegetarians may be more 
likely to consume larger portions than meat-eaters; there-
fore, a single serving size FFQ may underestimate their 
intakes of these foods and thus most nutrients.
When investigating the possible dietary factors influencing 
the CRC risk in British vegetarians, it is important to note that 
in contrast to the USA, the UK (as well as most of Europe) 
is a low-selenium (Se) area [23]. To illustrate the magnitude 
of the difference, mean daily Se intakes are approximately 
40 μg per day in Europe, and 93 μg in American women and 
134 μg in American men [24]. For reference, the daily level 
of intake currently recommended in the UK for individuals 
is 1 μg of Se per kg of body weight, which in practical terms 
translates to recommended intakes of 60 and 75 μg/day for 
females and males, respectively [25].
Given that Se status has been implicated in cancer risk in 
humans [24, 26], and that vegetarians in low-Se areas have 
lower Se intake and status than non-vegetarians (Table 1), 
it seems prudent to explore the speculative hypothesis that 
it may have been involved in the CRC risk in the studies of 
British vegetarians.
Interestingly, there is scant evidence to support the 
notion that a vegetarian diet in the UK may upregulate 
some mechanisms involved in the development of CRC. 
Joosen et al. [27] carried out two small, randomized crosso-
ver studies comparing the short-term effect of a vegetarian 
diet with omnivorous diets containing either red or pro-
cessed (nitrite-preserved) meats on endogenous nitrosation 
and DNA damage. In both of these comparisons, there were 
significantly more faecal water-induced DNA strand brakes 
in Caco2 cells in the vegetarian diet groups, as measured by 
the comet assay. The measurement of faecal water genotox-
icity suffers from considerable technical difficulties [28], 
and hence the described results should be interpreted with 
due caution. That being said, it is reasonable to expect at 
least one aspect of the vegetarian diet in the UK to nega-
tively influence the CRC risk, given that its significantly 
decreased risk has not been observed in British vegetarians, 
despite no intake of red and processed meats and higher 
intake of fibre than that of meat-eaters [1, 15], as well as a 
higher frequency of bowel movements [29].
Selenium and cancer in humans
Se is an essential nutrient, which is utilized for the expres-
sion of 25 different selenoprotein-encoding genes. The 
majority—and possibly all—of the selenoproteins are 
involved in the regulation of the redox status [30]. Some 
of them, namely glutathione peroxidases (GPxs), 15 kDa 
selenoprotein, Se-transport protein selenoprotein P (SePP) 
and thioredoxin reductases, have been implicated in 
tumourigenesis or cancer spread [26]. Although the biol-
ogy of Se is highly suggestive of a protective effect against 
cancer, which indeed has been shown in various animal 
models [29], the findings from studies in humans have 
been conflicting. It is currently unclear whether or not Se 
intake has a direct influence on cancer risk in humans, and 
more specifically CRC risk in the context of the current 
review.
The WCRF Expert Panel has judged foods containing 
Se to be a probable factor decreasing the risk of prostate 
cancer, and that there is limited-suggestive evidence for the 
same effect of this food group in the context of CRC, lung 
and stomach cancers [31]. In the subsequent WCRF Con-
tinuous Update Project (CUP) report on prostate cancer, 
judgement was made in regard to “low blood levels of Se” 
rather than the intake of foods from this food group, and 
the level of evidence was downgraded to limited-suggestive 
[32]. In the WCRF CUP report on CRC, the level of evi-
dence for selenium’s effect on CRC risk was also down-
graded (to limited-no conclusion), both in regard to foods 
containing Se and supplementary Se [1].
A recent Scientific Advisory Committee on Nutrition 
position statement on selenium and health concluded that 
“in the context of the levels studied, data do not suggest a 
protective association between higher Se intake or status 
in relation to prostate or lung cancers, and data are insuf-
ficient to establish whether or not selenium is associated 
with the risk of developing breast or colorectal cancers 
[33]”. The 2014 update of the Cochrane review on Se and 
cancer prevention came to similar conclusions [34]. That 
being said, such reviews rely heavily on the results of two 
major trials described below, conducted in the American 
population with largely adequate baseline Se status.
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The strongest evidence of a protective effect of Se 
against CRC comes from the Nutritional Prevention of 
Cancer (NPC) trial—a double-blind, placebo-controlled 
randomized trial of treatment with 200 μg Se per day in 
1312 subjects from south-eastern USA with a history of 
non-melanoma skin cancer, which was also the primary 
outcome [35]. After a mean follow-up of 4.5 years, there 
was no effect of Se on the primary outcome, but there was 
a significant 50% reduction in cancer mortality, as well as 
reduction in cancer incidence of 37% for all cancers, 67% 
for prostate cancer, 58% for CRC and 46% for lung cancer. 
However, the follow-up was extended to 7.9 years in a non-
blinded fashion, by the end of which period the incidence 
remained significantly reduced only for total (25%) and 
prostate (52%) cancers [36], as well as lung cancer in sub-
jects in the bottom tertile of baseline plasma Se (<106 ng/
ml) [37].
The results of the largest double-blind, placebo-con-
trolled randomized trial to date (35,533 subjects), the Sele-
nium and Vitamin E Cancer Trial (SELECT), investigating 
the effect of Se supplementation (200 μg/day) on prostate 
cancer incidence with CRC as one of the secondary out-
comes, have been null [38]. However, the baseline Se sta-
tus was likely too high for any potential benefit to manifest 
itself. The median baseline serum Se was 136 ng/ml [38], 
while in the NPC trial the median baseline plasma Se was 
113 ng/ml [36] (plasma and serum Se assays yield similar 
values). Also, few subjects in the SELECT trial had base-
line serum Se below 106 ng/ml, which was the plasma Se 
range in the NPC trial for which there was the strongest 
evidence of beneficial effects of Se supplementation on 
prostate cancer risk. Concurrently, there was no evidence of 
benefit in the highest baseline Se status category (>123 ng/
ml) in the NPC trial [36, 39].
Even before the results of SELECT were available, Ray-
man proposed that due to the lower Se status of Europeans, 
Europe was a more suitable geographical area for conduct-
ing a primary prevention Se trial the likes of SELECT, as 
stronger effects would be expected in such a population 
[26]. Other than the baseline Se status of the study popula-
tion, another issue which is recommended to be taken into 
account in study design of future Se trials is the measure-
ment of single nucleotide polymorphisms influencing Se 
metabolism, which may have contributed to the conflicting 
findings on Se and cancer risk in humans [40]. Moreover, 
Se status assessment itself represents a challenge, as rela-
tively little is known about the performance of currently 
used biomarkers as indices of long-term Se exposure. In a 
recent pooled analysis of individual participant data from 
fifteen prospective studies, blood Se concentration (short-
term exposure biomarker) was not associated with risk of 
total prostate cancer, while nail Se concentration (longer-
term exposure biomarker) was inversely associated with 
this risk [41]. These results call for more attention being 
paid to Se exposure assessment in future studies, as well as 
for a reappraisal of the Se-prostate cancer relationship.
In principle, the current understanding of the impact 
of Se on cancer risk, if any in humans, suggests that it is 
largely mediated via the influence of Se status on the 
expression of selenoproteins, with different selenopro-
teins having different saturation plasma/serum Se thresh-
olds [30]. Both observational data in humans [42], as well 
as basic research on Se [43] suggest the existence of a 
U-shaped curve—or ‘a split “Dr. Jekyll and Mr. Hyde” per-
sonality’ of some selenoproteins, as illustratively described 
by Hatfield and colleagues [43]—of the Se status or intake 
and the anti- or pro-tumourigenic effects. Anti-tumouri-
genic effects of Se have been observed in animal studies 
utilizing doses of Se an order of magnitude higher than 
required for saturation of most selenoproteins’ expression 
[30]. This implies that either non-selenoprotein Se com-
pounds—i.e. low molecular weight Se-metabolites—exert 
such effects or some under-researched, and possibly even 
undiscovered, selenoprotein(s) (e.g. those expressed by 
immune cells) have substantially higher Se requirements 
for maximum expression.
In the context of observational studies, it is reasonable 
to assume that revealing a ‘true’ Se-cancer risk association 
may only be possible, when the range of Se statuses in the 
study sample encompasses both deficient or suboptimal, as 
well as optimal concentrations of selenoproteins relevant 
to a particular type of cancer [44].This may have been the 
case in the recently published case–control study nested in 
the whole EPIC cohort on Se status and CRC risk [45]. It 
found that serum levels of SePP were inversely associated 
with CRC risk, with the association being more apparent in 
women, while serum Se was significantly associated with 
CRC risk only in women, and not in both sexes combined. 
The finding of the associations being more evident in 
women is particularly relevant to the EPIC-Oxford cohort, 
in which women constitute 78% of all subjects (albeit no 
evidence of effect modification of CRC risk in vegetarians 
by sex was reported in any of the publications on cancer 
incidence or mortality in EPIC-Oxford [9–12]).
Taking a step back—what is actually “selenium”?
It should be emphasized that unlike many other minerals 
of nutritional relevance, dietary Se is not a discrete sub-
stance, but rather a group of compounds containing Se 
[46], which have different metabolic pathways [47], as well 
as half-lives and Se bioavailabilities (which are generally 
high) [48]. Simply drawing attention of a reader with basic 
knowledge of chemistry to the fact that Se has four oxida-
tion states of -II, 0, IV and VI is likely to be instantaneously 
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and intuitively informative of the biochemical diversity and 
complexity to be expected. Briefly, Se is present in foods 
mostly as inorganic Se (selenate, selenite), selenomethio-
nine (SeMet), methylselenocysteine (MeSeCys) and sele-
nocysteine (SeCyS) [46–50].
Selenite and SeMet are generally the predominant forms 
in plants commonly consumed by humans, with notable 
exceptions of the Se-accumulating cruciferous and allium 
vegetables, in which substantial proportions of total Se 
comprise of Se-methyl-selenocysteine and ɣ-glutamyl-Se-
methyl-selenocysteine [46, 47]. For animal products, spe-
ciation of Se depends on the baseline Se status and whether 
or not the feed is fortified with inorganic Se [46, 47], which 
is a common practice in some low-Se countries, includ-
ing the UK—albeit not mandatory and permissible only 
at a low level [51]. Provision of inorganic Se increases the 
SeCys content in animal tissues compared to animals eat-
ing Se-containing plant foods, which in turn increases the 
SeMet content of the tissues [46, 47]. It is thus of note that 
differences in Se speciation in animal products between the 
UK and high-Se areas of USA can be expected, which may 
be of relevance to the differences in relative risk of CRC 
between British and American vegetarians. Se speciation in 
fish and shellfish varies greatly between species and may 
include a substantial proportion of inorganic selenium [52]. 
Although Se content in this food group is generally high—
albeit variable—it may be somewhat less available than 
from other foods [46–48].
Since the metabolic pathways of all Se-containing com-
pounds intersect at a common metabolite, hydrogen sele-
nide (H2Se), it is theoretically possible for all these com-
pounds to be equally utilized for selenoprotein expression. 
However, due to high reactivity of selenides with oxygen 
and metals, H2Se may not be freely available in sufficient 
quantities as to not be a limiting factor in some of the Se 
metabolic pathways [50]. Also, there is a major differ-
ence between the two predominant dietary Se compounds, 
SeMet and SeCys, in that the former can be incorporated 
non-specifically into proteins by replacing methionine, 
which allows for storing Se in the organism [49]. This 
may offer a distinct advantage of prolonged maintenance 
of Se status by a given dose of Se compared to other Se 
compounds [49]. However, Se from SeMet—when protein-
bound—may be less readily available for conversion to 
SeCys and further Se metabolism [53]. Indeed, it has been 
recently shown in a randomized clinical trial in healthy 
men that selenised yeast (a mixture of Se compounds), but 
not SeMet, was effective in reducing the levels of oxida-
tive stress biomarkers at similar increases in plasma Se in 
both intervention arms [54]. The characteristics of SeMet 
outlined above may serve as a yet another alternative and/
or partial explanation for the conflicting results of the NPC 
trial, in which selenised yeast was used, and SELECT, 
which utilized SeMet [35, 38, 48, 49, 53, 54].
Appreciating the fact not all dietary Se is ‘created equal’ 
is important for critical interpretation of studies on health 
effects of Se, as well as the hypothesis presented in the cur-
rent review.
Are vegetarians in the UK at increased risk of low 
selenium status?
A 7-day duplicate diet study in the UK has found the Se 
content of approximately 50 vegetarian diets to be 28 μg/
day [55], which was lower than the estimated 39 μg/
day intake of the general population [55, 56]. Data on Se 
intakes in British vegans estimated from food records sug-
gest insufficient intakes [57], however, unlike for many 
other nutrients, this is not a reliable measure of Se dietary 
intake due to large within-food variation of Se content [58]. 
Se content of vegetarian diets has also been evaluated by 
means of a duplicate diet study in Belgium [59] and in 
Sweden [60]. The mean Se content of 24 h duplicates of 
vegetarian diets from Belgium was only 13 μg, compared 
to 50 μg in non-vegetarian diets and 34 μg in macrobiotic 
diets (i.e. largely vegetarian diets, allowing low consump-
tion of animal flesh, particularly fish, which are a good 
source of Se [61]). A 4-day duplicate vegan diet samples 
analysis from Sweden revealed daily Se content of only 
7.8 μg, compared to the already low 31 μg in a Swedish 
mixed diet of elderly subjects [62]. Surprisingly, a similar 
study by the same group regarding lactovegetarian diets 
found Se content of 68 μg/day in men and 61 μg/day in 
women [60]. According to the authors: “This […]might 
partly be explained by the fact that many of the food items 
[…] were imported, and it is possible that these products 
were grown in areas that are rich in selenium.”
Only one study directly assessing Se status in British 
vegetarians was identified. Based on the analysis of toe-
nail concentrations of this mineral in the UK, Judd and 
colleagues have suggested that vegetarians and vegans 
may be at increased risk of Se deficiency [63]. The 57 
vegetarians and vegans under study had mean toenail Se 
concentrations of 541 ng/g, which was significantly lower 
than 685 ng/g in the 67 meat-eaters matched for sex and 
age. Also, these concentrations were significantly lower 
in vegans (n = 34) than in vegetarians (n = 23) at 506 vs 
591 ng/g. This may have been at least in part due to eight 
vegetarians who reported occasional consumption of tuna 
and had mean concentrations of 644 ng/g. This study was 
published as a short communication only and unfortu-
nately, it was not stated directly whether or not vegetarians 
and vegans under study dwelled in the same geographical 
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area as non-vegetarian controls, who resided in Norfolk—a 
relatively high-Se area within the UK [63].
Plasma Se was assayed in selected participants of the 
whole EPIC cohort in the nested case-control study of Se 
status and prostate cancer risk, which included few vegetar-
ians from the EPIC-Oxford cohort [64]. Overall, there were 
10 vegetarians and fish-eaters (pesco-vegetarians) each, 56 
meat-eaters and no vegans in this analysis. Mean plasma Se 
values were 68 ng/ml in vegetarians and 81 ng/ml in fish-
eaters, compared to 77 ng/ml in meat-eaters (unpublished 
data). The differences between diet groups were not tested 
for statistical significance due to the secondary nature of 
the data, and low numbers of vegetarians and fish-eaters. 
However, they are in agreement with the overall body of 
evidence showing lower Se status in vegetarians in low-Se 
areas and suggest that the same pattern may be present in 
the EPIC-Oxford cohort—which is one of the underlying 
assumptions for the hypothesis presented in the current 
review. (Similarly low numbers of vegetarians and fish-
eaters from the EPIC-Oxford cohort were included in the 
EPIC-nested case-control study of serum Se and SePP, and 
CRC risk [45] (personal communication with Hughes and 
Fedirko), also precluding an analysis of Se status by diet 
group in the EPIC-Oxford cohort).
Available data from other European, low-Se coun-
tries consistently [65–72], but not unanimously [73, 74], 
show lower blood parameters of Se status in vegetarians 
and vegans compared to non-vegetarians. The results of 
two studies by Krajcovicová-Kudlácková et al. [73, 74] 
from Bratislava, Slovakia, which have observed higher 
Se status in vegetarians than in non-vegetarians, repre-
sent the only discrepancy within the studies of Se status 
in European vegetarians. One of the two studies [74] was 
published in a non-Medline indexed journal and its full 
text or abstract is not available. It was only cited in the 
discussion of the other study [73] which found higher 
plasma Se in vegetarians, as evidence of previous similar 
findings (without specifying which Se status biomarkers 
were used in it). The authors did not provide an in-depth 
discussion of the possible reasons for the inconsistency 
of their findings with the rest of the literature. Also, the 
manuscript was lacking in information on preanalyti-
cal sample handling and adequate quality control meas-
ures, without which the validity of these data cannot be 
critically assessed. Similarly, no information was given 
on methods of recruitment of vegetarians and ascertain-
ment of adherence to vegetarian diet. Should they have 
been self-reported vegetarians, a substantial proportion of 
them may have in fact been non-vegetarians [75]. Assum-
ing the validity of the results, one potential explanation 
for these unexpected findings stems from the Swedish 
duplicate diet study reporting higher Se content in lac-
tovegetarian diets, which the authors proposed to be due 
to high intake of foods imported from high-Se areas [61]. 
Three other subsequent studies by a different group from 
Bratislava yielded opposite results in regard to plasma Se 
and other measures of Se status [65–68].
Another ‘special case’ study is an analysis in Finnish 
vegans and non-vegetarians [72]. It found lower serum Se 
in vegans; however, the mean values in both groups were 
noticeably higher than in other European studies. This is 
because Finland has national legislation which mandates 
adding Se to fertilizers [76].
The results of these and other identified published 
studies of Se status in European vegetarians, as well as 
their Se intakes assessed by duplicate diet analysis, are 
presented in Table 1. Currently, the most informative 
and commonly used biomarker of relevance to the anti-
tumourigenic Se properties is plasma Se [29], and for 
the sake of clarity and comparability, the specific values 
obtained in these studies are presented in Table 1 for this 
parameter only. For reference, optimal plasma/serum Se 
is approximately 120 ng/ml and there is no evidence of 
cancer risk reduction due to increases above this level 
[29], while levels below 70 ng/ml are considered Se defi-
ciency [58].
The results of two studies on Se status in European 
vegetarians merit particular attention. First, the 12 month 
trial assessing trace element status after adopting a lac-
tovegetarian diet from Sweden provided strong evidence 
that adopting such a diet in the context of a low-Se area 
decreases Se status, as measured by plasma Se (76 ng/ml 
at baseline vs ca. 55 ng/ml after 1 year; read from fig-
ure) [71]. Second, a cross-sectional study from Germany 
found no significant differences in extracellular GPx3 
activity between vegetarians and omnivores, but serum 
Se and SePP concentrations were significantly reduced in 
vegetarians (mean serum Se ca. 74 vs. 93 ng/ml in omni-
vores; read from figure) [69]—the latter being particu-
larly relevant in the context of CRC [45].
The results of studies of Se status in European vegetar-
ians show that Se status as assessed by plasma or serum 
is ca. 10–20% lower in vegetarians than in non-vegetar-
ians (but suboptimal in both diet groups), and highlight 
the considerable contribution of animal products to total 
Se intake in low-Se areas. However, this is not the case 
in areas with high soil Se. In contrast to the findings 
from Europe, North American studies [77, 78], including 
one study in Adventist vegetarians [78], suggested simi-
lar and optimal Se status in vegetarians and omnivores, 
as assessed by whole blood Se [77], as well as selenium 
content and GPx activity of milk from vegetarian and 
non-vegetarian women [78].
Overall, the results of European including some British 
studies convincingly suggest that lower Se status in British 
vegetarians than that of meat-eaters is very likely.
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Changes in selenium intakes and status in the UK
A dramatic decrease in the Se status in the UK had been 
observed over the 1980s in longitudinal studies on same 
subjects, from mean serum/plasma Se in the range of 
approximately 110–120 ng/ml in both healthy adults and 
renal dialysis patients at the beginning of this decade 
(which were then among the highest in European coun-
tries [79]) to as low as ca. 70 ng/ml in Scotland at the 
beginning of the 1990s [80–82]. A cross-sectional study 
from late 1980s of a random sample of 1000 adults regis-
tered within one general practice in Scotland has observed 
even lower mean plasma Se of only 60 ng/ml [83].
It should be noted that based on soil and foodstuffs Se 
content comparison, lower Se status can be expected in 
Scotland—where 10% of the EPIC-Oxford cohort reside 
[15]—than in other parts of the UK [84, 76]. However, 
the differences are likely not to be substantial. A compar-
ison of Se status by UK region in the National Diet and 
Nutrition Survey (NDNS) 2000–2001 of a representa-
tive sample of the UK population found a difference of 
5 ng/ml in mean plasma Se between the “London and the 
South East” region, for which the results were the high-
est, and Scotland [85].
Only one further study from Scotland assessing Se status 
was identified for comparability with these findings. It was 
published in the year 2000, but carried out in an unspeci-
fied period, and it found mean plasma Se concentrations 
of 82 ng/ml [86], which may have been due to differences 
between the study samples of this and the previous studies 
[82, 83] or due to an actual increase in Se content in the 
foodstuffs in the Scottish market. In the 2000–2001 NDNS, 
the mean plasma Se in Scotland was 86 ng/ml [85]. Given 
the representativeness of the NDNS samples, i.e. likely 
including some ill individuals whose Se status can be com-
promised due to illness, somewhat lower mean Se status 
can be expected in them than in healthy volunteers, who 
constituted the samples of most other studies on Se status 
in the UK discussed in the current review.
The following mean plasma Se concentrations were 
obtained in this and other editions of the NDNS for the 
whole UK: 75 ng/ml in non-institutionalized elderly 
between 1994 and 1995 [87], 87 ng/ml in adults between 
2000 and 2001 [85] and 85 ng/ml in both adults and 
non-institutionalized elderly between 2008 and 2012 
[20]. The negligible difference in plasma Se (<1 ng/ml) 
between the two groups suggests that the results of the 
1994–1995 survey in the elderly [87] may have been due 
to a nadir of Se intake and status in the UK at that time, 
rather than lower Se status in the elderly than in younger 
adults. The findings of similar Se status in both groups in 
the 2008–2012 NDNS [20] are in agreement with other 
studies, which suggest that apparently healthy elderly 
subjects have similar [88, 89] or somewhat lower [90] Se 
status than younger adults.
The decrease in Se status in the UK was due to changes 
in Se content of food products available in the British 
market [91], largely resulting from the decline in imports 
of selenium rich wheat for breadmaking flour from North 
America [80].
The results of the UK Total Diet Study (TDS, a study of 
chemical analysis of commonly consumed foods, aiming to 
estimate mean nutrient contents of a typical diet) are not 
in full agreement with the findings on Se status in terms 
of the timing of Se intake/status decrease, suggesting that 
there was a steady Se content in British diets throughout 
the 1980s at ca. 60 mcg/day (although there seemed to be 
a decrease in Se status over this decade), with a sudden 
decrease (1991–1994) to ca. 40 mcg/day in the 1990s up 
to early 2000s, and a subsequent increase to 58 mcg/day 
in the year 2006 [32, 92]. It should be noted that TDS do 
not provide robust trend data [83] and no changes in food 
supply between 1991 and 1994 were noted, which could 
explain the sudden decrease [32]. They were most likely 
the result of differences in the choice of foods purchased in 
TDS [32], possibly inflating the actual Se content estimate 
of the average British diet in the 1991 measurement.
Recent Se status studies from the UK in non-repre-
sentative, healthy individuals suggest that there may have 
indeed been a rise in Se content of foods in the British 
market, reflected in plasma/serum Se concentrations in the 
90–100 ng/ml range [93]. Overall, there is strong evidence 
of a substantial decrease in Se intakes and status through-
out 1980s and early 1990s in the UK, and some evidence 
of a reverse J-shaped curve of Se intakes/status over the 
last three decades; however, high-quality data to ascertain 
this are lacking. Moreover, no changes in food supply were 
identified, which could explain the proposed increases in 
Se intakes/status over the late 1990s and 2000s.
While the data presented so far are in agreement with 
the hypothesis proposed in this review, the experience of a 
nationwide addition of sodium selenite to fertilizers in Fin-
land is the proverbial fly in the ointment. Universal use of 
fertilizers supplemented with inorganic Se was introduced 
in this country in 1985 due to very low Se soil content 
and Se intake [76]. No substantial changes were observed 
in cardiovascular mortality and cancer incidence trends, 
including the colon cancer incidence rate, however, as is 
always the case with such descriptive data, drawing causal 
inferences is severely limited. It can be argued that either 
other lifestyle and medical factors were stronger determi-
nants of disease outcomes than the improvement of Se sta-
tus, or that specifically sodium selenate had no appreciable 
effect on disease outcomes, which does not automatically 
rule out the possibility that other Se compounds might have 
favourably influenced these trends.
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Are the patterns of Se intake associated with the 
secular trends of CRC risk in British vegetarians?
As presented in Table 2, the patterns of CRC mortality or 
incidence in British vegetarians followed the presumed pat-
terns of changes in Se intake/status in the UK. First, the 
HFSS and OVS, which were carried out mostly during the 
relatively high-Se period in the UK, observed not statisti-
cally significant, 15% lower CRC mortality rates in veg-
etarians than in non-vegetarians [7, 8]. Arguably, the sam-
ple sizes in both studies were insufficient to detect small to 
moderate differences in site-specific cancer rates.
Second, the EPIC-Oxford study in which increased 
CRC incidence was observed in vegetarians [9], started 
soon after the Se intake/status in the UK likely substan-
tially decreased. When data from this point of follow-up 
in the EPIC-Oxford study were combined with data from 
the OVS, thus increasing the overall exposure of the study 
sample to Se, the relative incidence of CRC in vegetarians 
was 12% higher and no longer significant [10].
After additional follow-up, which took place during the 
period of possibly higher Se intake/status than the begin-
ning of the EPIC-Oxford study [20, 32, 86, 87, 91, 92], the 
CRC incidence in vegetarians relative to meat-eaters was 
virtually the same in the pooled data from the EPIC-Oxford 
study and OVS [11]. Moreover, the relative CRC incidence 
rate in vegans, who may be most at risk of low Se intakes 
in the UK [55], was 1.29 (0.81–2.07), albeit based only on 
19 cases [11]. Also, this analysis showed 34% lower CRC 
incidence in fish-eaters (pesco-vegetarians) than in meat-
eaters, with the earlier pooled analysis [10] and EPIC-
Oxford study alone [9] showing insignificantly lower CRC 
incidence in this diet group.
Fish are a rich source of Se [61]; therefore, the lower 
CRC risk in British fish-eaters than in vegetarians is con-
sistent with the proposed hypothesis of secular changes 
in Se status/intake modulating CRC risk. However, in the 
American Adventist Health Study 2, pesco-vegetarians 
also had significantly lower risk of CRC compared to non-
vegetarians, while vegetarians did not [6]. Data on Se sta-
tus of the cohort are not available and it is difficult to judge 
it based on the local soil Se concentrations, as the cohort 
is spread over the USA and Canada. Nevertheless, the Se 
status of Adventist cohorts is likely to be higher than in 
EPIC-Oxford, and hence the hypothesized positive impact 
of Se from fish is likely to be smaller in the USA, if at all 
Table 2  Temporal changes in Se intakes and Se status in adults, and CRC risk in vegetarians in the UK
Se selenium, CRC colorectal cancer, HFSS Health Food Shoppers Study, OVS Oxford Vegetarian Study
a Data from the UK Total Diet Studies (TDS) [33]. Note that TDS do not provide robust trend data— see text for details
b Data from the National Diet and Nutrition Survey, carried out in UK representative samples
c Non-institutionalized
Years Se intakea 
(μg/day)
Changes in mean plasma/serum Se (ng/ml) Studies on CRC risk in British vegetarians
1970s HFSS follow-up begins
 1974 60
1980s 63 Concentrations in the range of ca. 110–120 (among 
the highest in Europe) begin to decrease
OVS follow-up begins
 1985
1990s 60 Nadir of Se status with the lowest concentrations of 
60–70 observed in Scotland (likely slightly lower 
than in the rest of the UK)
EPIC-Oxford study follow-up begins
 1991
 1994 43
 1995 39 UK representativeb elderlyc 75
 1997 39 Scotland: 82 CRC risk insignificantly lower in vegetarians by 15% in both 
HFSS and OVS
2000s
 2000 34 UK representativeb adults: 87 (from 86 in Scotland to 
91 in London and the South East)
 2006 58 EPIC-Oxford CRC RR in vegetarians after 10.7 years mean 
follow-up: 1.39 (95% CI: 1.01–1.91)
EPIC-Oxford & OVS combined CRC RR in vegetarians after 
12.2 years mean follow-up: 1.12 (95% CI: 0.87–1.44)
2010s Concentrations in the ca. 90–100 range in healthy 
individuals, indicating a possible increase in Se 
status since the 1990s
UK representativeb adults and elderlyc: 85 both EPIC-Oxford & OVS combined CRC RR in vegetarians after 
14.9 years mean follow-up: 1.03 (95% CI: 0.84–1.28)
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existent. It is possible that other nutrients from fish (e.g. 
vitamin D, omega-3 fatty acids), their synergistic effect 
(i.e. fish itself), or some other aspect of diet or lifestyle 
common to American and British fish-eaters/pesco-vege-
tarians reduces the CRC incidence in these diet groups.
There is some evidence available to support the notion 
that fish may decrease CRC risk when comparing extreme 
consumption levels [94], but not when estimating relative 
risks per 100 g or per times per week consumed [1]. It 
should be kept in mind that fish-eaters in the EPIC-Oxford 
study are “fish-allowers,” rather than high fish consumers, 
with median fish intake of ca. 30 g/day in men and 24 g/
day in women, which is similar to that of meat-eaters [95]. 
24–30 g of fish translates to up to 21–26 μg of Se in the 
case of tuna [32], which is substantial compared to both 
recommended and usual Se intakes in the UK, while not 
representing a particularly high fish intake.
Conclusions
Whether or not Se status influences CRC risk in humans is 
a matter of ongoing debate. Null results in studies of CRC 
risk in British vegetarians [7, 8, 10, 11] are in disagree-
ment with the established effects of fibre, and processed 
and red meats on the risk of this type of cancer [1]. Se sta-
tus represents possibly the most pronounced difference in 
nutritional status between British (likely low Se status) and 
American vegetarians (likely adequate Se status), in whom 
significantly decreased CRC risk has been observed [5, 6]. 
Figure 1 shows the hypothesized effect modification of the 
influence of vegetarian diet on CRC risk by high- or low-Se 
area.
Authors of one of the European studies on Se status in 
vegetarians went as far as to suggest that “Se supplemen-
tation should be recommended to this risk group [vegetar-
ians] of the population” [65]. While undoubtedly Se is a 
micronutrient of concern in plant-based diets in Se-poor 
areas, it should be kept in mind that ensuring adequate vita-
min B12 supplementation (or planning of the diet in regard 
to fortified foods) is of primary importance both in vegans 
and considerable proportion of vegetarians. This basic need 
is often unmet, as reflected by depletion or deficiency rates 
in vegetarian populations ranging 10–90%—depending on 
the criterion of deficiency used and life-stage group under 
study, but regardless of type of vegetarian diet [96]. Thus, 
Fig. 1  Hypothesized effect modification of the influence of vegetarian diet and its components on colorectal cancer (CRC) risk by selenium (Se) 
status
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a food-based recommendation is desirable and Brazil nuts 
have been shown to improve Se status [97]. Depending on 
the soil Se concentration in the country of origin, Brazil 
nuts may have moderate to high-Se content, ranging from 
8 mcg/nut (5 g) in nuts grown in Bolivia, through 18 mcg/
nut in Brazil and 33mcg/nut in Peru, to 130mcg/nut when 
grown in northern countries of South America [98]. Either 
adequate, country of origin-dependant, “dosing” of Brazil 
nuts or use of dietary supplements should be exercised by 
plant-based diet followers in low-Se areas.
Changes in relative risk of CRC in British vegetarians 
follow the patterns of changes in Se intakes and status in the 
UK; therefore, the hypothesis that Se status in British veg-
etarians may influence their CRC risk is worthy of pursuing 
in future studies. The ongoing EPIC-Oxford study allows 
for such an opportunity, as blood samples were provided by 
19,500 of its participants. A biomarker based study of CRC 
risk in this population would cover a wide range of intakes, 
thus making a substantial contribution to the body of evi-
dence on the relationship between Se and CRC.
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